We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Southern Research Institute Signs Agreement with Absorption Systems to Provide Toxicology Services

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Southern Research Institute Signs Agreement with Absorption Systems to Provide Toxicology Services"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Southern Research Institute and Absorption Systems, LP announced that they have signed an agreement that will allow the two organizations to collaborate in providing contract research services in the areas of toxicology and bioanalytical services to biotechnology and pharmaceutical clients.

According to the agreement, Southern Research and Absorption Systems will work jointly to offer expanded preclinical development services to their clients for new compounds about to enter clinical development, and will conduct collaborative business development, co-marketing and scientific publication projects.

"We are very pleased to be working with Southern Research. This collaboration will allow us to combine Southern Research's world-renowned toxicology services and drug development expertise with Absorption System's expertise in bioanalytical services, metabolite profiling, and preclinical formulation development in order provide the highest quality services to the pharmaceutical and biotech industry," said Patrick Dentinger, president and CEO of Absorption Systems.

"The relationship with Absorption Systems will allow both companies to leverage our individual strengths for the benefit of our pharmaceutical and biotech clients by generating better and faster study data as new drugs move forward," said Tina Rogers, Ph.D., vice president of the Drug Development Division at Southern Research.